NeuBase Therapeutics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
NeuBase Therapeutics Inc
CIK #0001173281
EDGAR Form CIK 2011 - 2026
10-K [0001173281]
10-Q [0001173281]
3 [0001173281]
4 [0001173281]
5 [0001173281]
8-K [0001173281]
D [0001173281]
SC 13D [0001173281]
SC 13G [0001173281]
Form 13D/13G Filer Form 13D/13G Subject Filed
Symetryx Corp Neubase Therapeutics Inc [2023-08-31]
Titcomb Shawn Neubase Therapeutics Inc [2019-08-27]
Thadke Shivaji Neubase Therapeutics Inc [2019-07-22]
Stephan Dietrich A Neubase Therapeutics Inc [2019-07-22]
Carnegie Mellon University Neubase Therapeutics Inc [2019-07-22]
Kershner Trading Americas LLC Neubase Therapeutics Inc [2019-07-18]
Greenlight Capital Inc Neubase Therapeutics Inc [2019-07-16]
Slakter Jason Scott OHR Pharmaceutical Inc [2016-01-29]
Broadfin Capital LLC OHR Pharmaceutical Inc [2015-04-07]
Visium Asset Management LP OHR Pharmaceutical Inc [2014-07-11]
Hirschman Shalom OHR Pharmaceutical Inc [2014-03-24]
South Ferry 2 LP OHR Pharmaceutical Inc [2014-02-14]
Hirschman Orin OHR Pharmaceutical Inc [2014-02-14]
GCK Holdings Corp OHR Pharmaceutical Inc [2014-02-13]
Alpert Charles OHR Pharmaceutical Inc [2014-02-13]
Packer Paul OHR Pharmaceutical Inc [2013-06-28]
Form 3/4/5 Subject 2011 - 2026
Ohr Pharmaceutical Inc
Shiff Barry
Symetryx Corp
Shiff Aleta
Stephan Dietrich A
Branning Todd P
Richman Eric I
Prendergast Franklyn G
McDougall Gerald J
Goldstein Dov A MD
View All
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Ohr Pharmaceutical Inc NBSE
Common Stock, par value $0.0001
2023-09-18 Other 0 $0.00
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
2023-09-18 Sell 50,000 $1.19 59,500
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
2023-09-15 Sell 103,337 $1.26 130,205
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
2023-09-14 Sell 129,108 $1.44 185,916
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
2023-09-11 Sell 3,376 $1.44 4,861
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
2023-09-08 Sell 128,847 $1.53 197,136
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
2023-09-07 Sell 74,852 $1.80 134,734
Ohr Pharmaceutical Inc NBSE
Common Stock, Par Value $0.0001 per Share
2023-09-01 Buy 61,076 $0.98 59,854
Ohr Pharmaceutical Inc NBSE
Common Stock
2023-08-02 Option exercise 93,234 $0.02 1,865
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
2023-08-02 Option exercise 93,234 $0.00
Ohr Pharmaceutical Inc NBSE
Common stock
2023-03-16 Grant 54,200 $0.00
Ohr Pharmaceutical Inc NBSE
Common stock
2023-03-16 Grant 153,000 $0.00
Ohr Pharmaceutical Inc NBSE
Common Stock
2023-02-13 Option exercise 655,000 $0.00
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
2023-02-13 Option exercise 655,000 $0.00
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
2022-11-03 Grant 200,000 $0.00
Ohr Pharmaceutical Inc NBSE
Common Stock
2022-09-28 Option exercise 750,000 $0.00
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
2022-09-28 Option exercise 750,000 $0.00
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
2022-09-09 Grant 37,600 $0.00
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
2022-09-09 Grant 37,600 $0.00
Ohr Pharmaceutical Inc NBSE
Stock option (right to buy) · derivative
2022-09-09 Grant 37,600 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com